Precigen, Inc. Files 8-K on Financials
Ticker: PGEN · Form: 8-K · Filed: Aug 14, 2024 · CIK: 1356090
| Field | Detail |
|---|---|
| Company | Precigen, Inc. (PGEN) |
| Form Type | 8-K |
| Filed Date | Aug 14, 2024 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: financial-reporting, 8-k
TL;DR
Precigen dropped an 8-K detailing financials and exhibits. Check it out.
AI Summary
Precigen, Inc. filed an 8-K on August 14, 2024, reporting on its Results of Operations and Financial Condition, as well as Financial Statements and Exhibits. The filing details the company's financial performance and provides supporting documentation. Precigen, Inc. is incorporated in Virginia and headquartered in Germantown, Maryland.
Why It Matters
This filing provides investors with crucial updates on Precigen, Inc.'s financial health and operational performance, enabling informed investment decisions.
Risk Assessment
Risk Level: low — This is a routine financial filing and does not indicate any immediate or significant risks.
Key Players & Entities
- Precigen, Inc. (company) — Registrant
- August 14, 2024 (date) — Date of earliest event reported
- Virginia (jurisdiction) — State of incorporation
- Germantown, Maryland (location) — Principal executive offices
- Intrexon Corp (company) — Former company name
FAQ
What specific financial information is being reported in this 8-K?
This 8-K reports on the 'Results of Operations and Financial Condition' and 'Financial Statements and Exhibits' of Precigen, Inc.
When was this 8-K filing made?
The filing was made on August 14, 2024.
Where is Precigen, Inc. headquartered?
Precigen, Inc.'s principal executive offices are located at 20374 Seneca Meadows Parkway, Germantown, Maryland 20876.
In which state is Precigen, Inc. incorporated?
Precigen, Inc. is incorporated in Virginia.
Was Precigen, Inc. previously known by another name?
Yes, Precigen, Inc. was formerly known as Intrexon Corp.
Filing Stats: 477 words · 2 min read · ~2 pages · Grade level 10 · Accepted 2024-08-14 16:19:00
Filing Documents
- dp216654_8k.htm (8-K) — 22KB
- dp216654_ex9901.htm (EX-99.1) — 78KB
- image_001.jpg (GRAPHIC) — 2KB
- 0000950103-24-012201.txt ( ) — 280KB
- pgen-20240814.xsd (EX-101.SCH) — 3KB
- pgen-20240814_lab.xml (EX-101.LAB) — 33KB
- pgen-20240814_pre.xml (EX-101.PRE) — 22KB
- dp216654_8k_htm.xml (XML) — 3KB
02. Results of Operations and Financial Condition
Item 2.02. Results of Operations and Financial Condition. Attached as Exhibit 99.1 is a copy of a press release of Precigen, Inc., dated August 14, 2024, reporting its financial results for the quarter ended June 30, 2024. This information, including the Exhibit attached hereto, shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, except as shall be expressly set forth by specific reference in such filing.
Financial Statements and Exhibits
Financial Statements and Exhibits. (d) Exhibits. Exhibit No. Description 99.1 Press release dated August 14, 2024 104 Cover Page Interactive Data File (formatted as inline XBRL with applicable taxonomy extension information contained in Exhibits 101)
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Precigen, Inc. By: /s/ Donald P. Lehr Donald P. Lehr Chief Legal Officer Dated: August 14, 2024